Glenmark

SUMMARY OF THE ISSUE
The following is a general summary of the terms of the Issue. This summary should be read in conjunction
with, and is qualified in its entirety by, more detailed terms appearing elsewhere in this Preliminary
Placement Document, including under “Issue Procedure” and “Description of the Equity Shares”.
Issuer
Glenmark Pharmaceuticals Limited
Face Value Re. 1
Issue Price per
Equity Share
Issue Size
Rs. [●]
[●] Equity shares aggregating to Rs. [●] million
A minimum of 10% of the Issue Size i.e. up to [●] Equity Shares shall be available
for Allocation to Mutual Funds only. If no Mutual Fund is agreeable to take up the
minimum portion mentioned above, such minimum portion or part thereof may be
Allotted to other eligible QIBs
Floor Price
Rs. 221.00 per Equity Share.
Equity Shares issued
and outstanding
immediately prior to
the Issue
Equity Shares issued
and outstanding
immediately after
the Issue
Eligible Investors
Listing
Transferability
Restrictions
Closing
Ranking
Voting Rights of
Equity Shareholders
Dividends
250,868,118 Equity Shares, aggregating Rs. 250,868,118.
[●] Equity Shares
QIBs as defined in clause 2 (zd) of the SEBI
The Company has made applications to each of the Stock Exchanges to obtain inprinciple
approvals for listing of the Equity Shares issued pursuant to the Issue.
The Equity Shares being Allotted pursuant to this Issue shall not be sold for a
period of one year from the date of Allotment, except on the floor of the Stock
Exchanges.
The Allotment of the Equity Shares offered pursuant to this Issue shall be made on
or about [●] (the “Closing Date”).
The Equity Shares being issued shall be subject to the provisions of the Company’s
Memorandum of Association and Articles of Association and shall rank pari passu
in all respects with the existing Equity Shares including rights in respect of
dividends. The Equity Shareholders will be entitled to participate in dividends and
other corporate benefits, if any, declared by the Company after the Closing Date, in
compliance with the Companies Act. The Equity Shareholders may attend and vote
in shareholders’ meetings on the basis of one vote for every Share held. See the
“Description of the Equity Shares”.
For details, see “Description of the Equity Shares – Voting Rights”.
For details, see “Description of the Equity Shares – Dividend”.
vii